Medicina News by Xagena

Gastroenterology News by Xagena


Gastroenterology - GastroenterologyNews.net

Gastroenterology, GastroenterologyNews.net, Gastroenterology News,  Gastroenterology Xagena, Gastroenterology Newsletter,  Aggiornamento in Medicina, Gastroenterology Updates, Hepatitis News, Hepatitis Newsletter, Ulcerative Colitis Newsletter, Gastroenterology :: Drugs :: Updates, Hepatitis Newsletter, Hepatitis Updates,  
Ulcerative colitis
Adalimumab ( Humira ) is the key treatment for ulcerative colitis …
Sequential versus triple …
Sequential versus triple therapy for the … The efficacy of sequential …
Pediatric Crohn disease …
Pediatric Crohn disease: efficacy and safety of Adalimumab after …
Hepatitis
Chronic hepatitis C genotype 1b patients with prior Telaprevir …
therapy with Adalimumab has …
… has a beneficial effect on bone metabolism … therapy on bone …
Crohn’s disease: Vedolizumab …
Crohn’s disease: Vedolizumab as … separate induction and …
Anti-TNF-naive Crohn’s …
Anti-TNF-naive Crohn’s disease: clinical, biological, and …
Helicobacter pylori
Increased risk of cancer linked to high-salt diet and Helicobacter …
Regorafenib in the treatment of …
Regorafenib in the treatment of metastatic … with metastatic …
Pouchitis
Anti-TNF therapy in patients with antibiotic refractory pouchitis or …